Clinical nutrition market share research by applications and regions for 2017-2024

The world is witnessing a rise in the number of disorders subject to the lack of proper nutrition, as per scientists. Clinical nutrition market size is expected to grow exponentially subject to this very factor. Clinical nutrition entails the administering of nutritional products to patients suffering from malnutrition, metabolic disorders, and other chronic diseases. It also involves the diet supply and management for in patients and out patients. The growing geriatric population, rise in the number of metabolic disorders, and an increase in the number of premature births are key factors that will propel Clinical Nutrition Market, which was worth USD 40 billion in 2015, and will grow at a CAGR of 7% over 2017-2024.

As per reliable statistics, metabolic syndrome affects more than 50% of the U.S. population aged above 60, and approximately 35% of the U.S. adult population. The aged have been found to be more susceptible to metabolic disorders, loss of appetite, and chronic disease due to lack of nutrition, which will propel the demand for vitamins, minerals, and other nutrients, thereby fueling clinical nutrition industry trends.

Request sample copy @ https://www.gminsights.com/request-sample/detail/1324

Clinical nutrition market is controlled by a specific number of leading players accounting for a major share. Companies such as Hospira, Baxter International, Danone, B Braun Melsungen, Nestle, Mead Johnson, Perrigo, Fresenius Kabi, Abbott Laboratories, and H. J. Heinz mainly operate in this industry, and are engaged in tried-and-tested as well as innovative growth strategies to expand their business and provide a competitive edge to their rivals. Recently, Nestle was in the news for researching on developing nutritional solutions that contribute toward healthy aging. Baxter International, Inc., has also developed a comprehensive guide that’ll help develop smart infusion system drug libraries.

Subject to the fact that clinical nutrition is related to health, diet, and hygiene, customers prefer to purchase branded products from established firms. Since clinical nutrition market is characterized by consumer preferences for selected, well-established brands, it may pose a threat to new entrants, who may need to face stiff competition in clinical nutrition industry from the already established bandwagon of companies.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1324

High birth rate, especially in emerging economies, will stimulate clinical nutrition market demand. Premature children are most vulnerable to malnutrition and metabolic syndrome, owing to which the demand for clinical nutrition will be subsequently high in countries such as India and China. India clinical nutrition industry is anticipated to grow at a rate of 9% over 2017-2024, pertaining to the high rate of malnutrition, increase in the number of chronic disorders, and the ever-growing population. The government however, has been laying down favorable norms to improve home-based healthcare, availability of high-grade nutrition, and enhance healthcare infrastructure, which will further propel India clinical nutrition market size.

Speaking of emerging economies, China contributed to more than 35% of the regional clinical nutrition industry, and was worth more than USD 6 billion in 2015. Despite the government’s implementation of the one-child policy, the country is still home to more than 1.38 billion, as per the 2015 census. The growing population base, increasing geriatric population and the subsequent rise in chronic diseases, and the high birth rate will stimulate China clinical nutrition market, which is set to grow at a CAGR of 9% over 2017-2024. Additionally, the country’s high economic growth and improving healthcare facilities should also fuel the demand.

Pertaining to the growth of clinical nutritional market in India and China, APAC is likely to experience a massive growth over the years ahead. Having accounted for more than 40% of global clinical nutrition market in 2015, Asia Pacific industry size will exceed USD 30 billion by 2024, subject to the increasing demand for infant nutrition products.

Infant products accounted for more than 55% of clinical nutrition market in 2015, and is likely to grow at a CAGR of 9% over 2017-2024. This growth can be credited to the increase in the number of pre-mature births, metabolic disorders, and a high birth rate across the emerging economies.

Milk based infant products contributed to more than 70% of infant clinical nutrition industy share in 2015, and will cross a revenue of more than USD 35 billion by 2024, subject to the rising inclination toward tasty, tolerant, healthy milk-based nutritional products for toddlers.

Parenteral nutritional products are fairly prominent in the product landscape of clinical nutrition market, having held a valuation of more than USD 4.2 billion in 2015. These products are further categorized into carbohydrates, amino acids, and fats, and help achieve balanced metabolism, essential nutrition, and renewed body strength. Parenteral clinical nutrition industry size is anticipated to cross a valuation of USD 7 billion by 2024, growing an annual growth rate of 5% over 2017-2024. This growth can be accredited to the high product demand for patients suffering from cancer, diabetes, and HIV/AIDS, the incidences of which also seem to be on an incline.

Amino acids accounted for more than 40% of parenteral clinical nutrition market share in 2015 and will grow substantially over 2017-2024, subject to the fact that they effectively help address the body metabolism issues. Fats on the other hand, will witness a growth of 6% over 2017-2024, and are predicted to observe the highest gains in parenteral clinical nutrition industry.

Parenteral products are quite prominent in the U.S.A., subject to the growing incidences of cancer and diabetes, in addition to the rise in chronic disorders and metabolic syndrome. In 2015, U.S. clinical nutrition market size was worth more than USD 8 billion, and will grow at a rate of 6% over 2017-2024, pertaining to the rising elderly population base, advanced healthcare facilities, and favorable government policies subject to medical care.

Europe is expected to contribute substantially to global clinical nutrition industry. In 2015, UK accounted for more than 17% of Europe clinical nutrition market share, subject to the increasing disposable incomes of patients and the rising expenditure on healthcare. The same year witnessed Germany contributing to more than 18% of Europe clinical nutrition industry share, pertaining to the highly-advanced healthcare infrastructure and the rising geriatric population.

Of late, clinical nutrition market has witnessed a paradigm shift from parenteral products to enteral products, as the latter can be used for a longer duration. In 2015, enteral products held more than 30% of clinical nutrition industry and will observe a stupendous rise, subject to increased product preference pertaining to its long-term usage.

Enteral products have been gaining prominence across Latin America and South America. Brazil accounted for more than 45% of clinical nutrition market in 2015, while Mexico is anticipated to witness a CAGR of 9% over 2017-2024, subject to the improved healthcare facilities, growing cases of malnutrition, and the prevalence of chronic diseases. Latin America clinical nutrition industry is projected to cross a revenue of USD 6 billion by 2024, growing at a CAGR of 8% over 2017-2024.

Leading companies across the world have been adopting advanced technologies to improve the quality and nutritional value of products, thereby stimulating clinical nutrition market. The government has also designed a range of guidelines to be followed to improve the quality of patient nutrition and diet. In addition, the governments of various countries have been providing favorable reimbursement policies and enforcing strict regulations to regulate the supply and management of clinical nutrition, which will transform clinical nutrition industry outlook. The high prevalence of metabolic disorders and the rising trend of excellent home-based care will fuel the market size over the years to come.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.